Literature DB >> 31549859

Upregulation of SCNN1A Promotes Cell Proliferation, Migration, and Predicts Poor Prognosis in Ovarian Cancer Through Regulating Epithelial-Mesenchymal Transformation.

Lan Wu1,2, Zhong-Hui Ling1,2, Huan Wang1,2, Xin-Yan Wang1,2, Jing Gui1,2.   

Abstract

Background: There is little knowledge about the biological roles and clinical significance of SCNN1A in ovarian cancer. Thus, the objective of this study was to investigate the biological functions and prognosis value of SCNN1A in ovarian cancer to further seek a potential therapeutic target for patients with ovarian cancer. Materials and
Methods: First, the expression level of SCNN1A in ovarian cancer samples obtained from ONCOMINE database was determined, and its expression in cell lines was also investigated. Moreover, correlation analysis was performed to determine the relationship between SCNN1A expression and prognosis in ovarian cancer patients according to the data obtained from GEPIA database and Kaplan-Meier plotter website. The biological roles of SCNN1A on cell growth, migration, and invasion were then examined by knockdown of SCNN1A in ovarian cancer cell line SK-OV-3. Ultimately, Western blotting analysis was carried out to investigate the expression of epithelial-mesenchymal transformation markers (including E-cadherin, N-cadherin, Vimentin, and Snail) after silencing SCNN1A.
Results: Based on the ONCOMINE-related data and cell lines, SCNN1A was observed to be overexpressed in ovarian cancer samples and cell lines. Survival analysis showed that high expression of SCNN1A was associated with poor overall survival and progression-free survival in ovarian cancer patients. In addition, SCNN1A silence remarkably blocked SK-OV-3 cell growth ability, migration, and invasion potential. Western blotting results showed that SCNN1A silence led to an increase in E-cadherin, whereas a decrease in N-cadherin, Vimentin, and Snail in SK-OV-3 cells. Increased E-cadherin and decreased N-cadherin, Vimentin, as well as Snail inhibited cell invasion of ovarian cancer. Conclusions: SCNN1A might exert crucial roles in cell growth and invasion and migration in ovarian cancer, and might be a potential indicator for prognosis and a therapeutic target for ovarian cancer patients.

Entities:  

Keywords:  SCNN1A; epithelial–mesenchymal transformation; invasion; migration; ovarian cancer; proliferation

Mesh:

Substances:

Year:  2019        PMID: 31549859     DOI: 10.1089/cbr.2019.2824

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  9 in total

1.  Comparison of Gene Expression Profiles of Signet Ring Cell Carcinoma and Poorly Cohesive Carcinoma in Early Gastric Cancer.

Authors:  Min Kyung Yeo; Sun Hyung Kang; Ku Bean Jeong; Hyun Seok Lee; Hong Jae Jeon; Hyuk Soo Eun; Eaum Seok Lee; Hee Seok Moon; Seok Hyun Kim; Jae Kyu Sung; Byung Seok Lee; Hyun Yong Jeong
Journal:  Clin Med Insights Oncol       Date:  2022-05-18

2.  Common pathways and functional profiles reveal underlying patterns in Breast, Kidney and Lung cancers.

Authors:  Sergio Romera-Giner; Zoraida Andreu Martínez; Francisco García-García; Marta R Hidalgo
Journal:  Biol Direct       Date:  2021-05-26       Impact factor: 4.540

Review 3.  Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment.

Authors:  Concetta Altamura; Maria Raffaella Greco; Maria Rosaria Carratù; Rosa Angela Cardone; Jean-François Desaphy
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

4.  Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.

Authors:  Jian Lei; Zhen-Yu He; Jun Wang; Min Hu; Ping Zhou; Chen-Lu Lian; Li Hua; San-Gang Wu; Juan Zhou
Journal:  Cancer Med       Date:  2021-03-19       Impact factor: 4.452

5.  Regulatory patterns analysis of transcription factor binding site clustered regions and identification of key genes in endometrial cancer.

Authors:  Xiaohan Tang; Junting Wang; Huan Tao; Lin Yuan; Guifang Du; Yang Ding; Kang Xu; Xuemei Bai; Yaru Li; Yu Sun; Xin Huang; Xiushuang Zheng; Qianqian Li; Bowen Gong; Yang Zheng; Jingxuan Xu; Xiang Xu; Zhe Wang; Xiaochen Bo; Meisong Lu; Hao Li; Hebing Chen
Journal:  Comput Struct Biotechnol J       Date:  2022-01-20       Impact factor: 7.271

6.  HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation.

Authors:  Jinhai Chang; Xuguang Hu; Jinniang Nan; Xianghua Zhang; Xintian Jin
Journal:  Mol Med Rep       Date:  2021-09-24       Impact factor: 2.952

7.  SCNN1A Overexpression Correlates with Poor Prognosis and Immune Infiltrates in Ovarian Cancer.

Authors:  Jiayan Lou; Lingjia Wei; He Wang
Journal:  Int J Gen Med       Date:  2022-02-18

8.  Knocking down Sterol regulatory element binding protein 2 (SREBF2) inhibits the Serine Protease 8 (PRSS8) /sodium channel epithelial 1alpha subunit (SCNN1A) axis to reduce the cell proliferation, migration and epithelial-mesenchymal transformation of ovarian cancer.

Authors:  Chunyan Cai; Yumei Zhang; Xing Peng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  Highly expressed IFITM10 is associated with early diagnosis and T stage of gastric cancer.

Authors:  Yuanda Liu; Jingjing Liu; Zhenwei Tian; Zhaoyu Zhang; Tong Liu; Chao Chen; Xiaohuan Tang; Jiaming Zhu
Journal:  Transl Cancer Res       Date:  2021-01       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.